NIZATIDINE, AN H-2-RECEPTOR ANTAGONIST - DISPOSITION AND SAFETY IN THE ELDERLY

被引:10
作者
CALLAGHAN, JT
RUBIN, A
KNADLER, MP
BERGSTROM, RF
机构
[1] ELI LILLY & CO,LILLY RES LAB,LILLY LAB CLIN RES,INDIANAPOLIS,IN 46285
[2] INDIANA UNIV,SCH MED,DEPT MED,INDIANAPOLIS,IN 46202
[3] INDIANA UNIV,SCH MED,DEPT PHARMACOL,INDIANAPOLIS,IN 46202
关键词
D O I
10.1002/j.1552-4604.1987.tb03075.x
中图分类号
R9 [药学];
学科分类号
1007 ;
摘要
引用
收藏
页码:618 / 624
页数:7
相关论文
共 10 条
[1]   INTRAVENOUS NIZATIDINE KINETICS AND ACID SUPPRESSION [J].
CALLAGHAN, JT ;
BERGSTROM, RF ;
OBERMEYER, BD ;
KING, EP ;
OFFEN, WW .
CLINICAL PHARMACOLOGY & THERAPEUTICS, 1985, 37 (02) :162-165
[2]  
CHIN TWF, 1983, AM ASS CLIN CHEM, V5, P1
[3]   AGE AND RENAL CLEARANCE OF CIMETIDINE [J].
DRAYER, DE ;
ROMANKIEWICZ, J ;
LORENZO, B ;
REIDENBERG, MM .
CLINICAL PHARMACOLOGY & THERAPEUTICS, 1982, 31 (01) :45-50
[4]   THE EFFECT OF AGE ON RANITIDINE PHARMACOKINETICS [J].
GREENE, DS ;
SZEGO, PL ;
ANSLOW, JA ;
HOOPER, JW .
CLINICAL PHARMACOLOGY & THERAPEUTICS, 1986, 39 (03) :300-305
[5]   CIMETIDINE IN ELDERLY PATIENTS - REVIEW OF USES AND RISKS [J].
JENIKE, MA .
JOURNAL OF THE AMERICAN GERIATRICS SOCIETY, 1982, 30 (03) :170-173
[6]  
KNADLER MP, 1985, DRUG METAB DISPOS, V14, P175
[7]   BLOOD LEVEL OF CIMETIDINE IN RELATION TO AGE [J].
REDOLFI, A ;
BORGOGELLI, E ;
LODOLA, E .
EUROPEAN JOURNAL OF CLINICAL PHARMACOLOGY, 1979, 15 (04) :257-261
[8]  
SAWYER D, 1982, AM J HOSP PHARM, V38, P188
[9]  
SIMON B, 1982, RANITIDINE, V227, P181
[10]   EFFECTS OF CIRRHOSIS AND AGING ON THE ELIMINATION AND BIOAVAILABILITY OF RANITIDINE [J].
YOUNG, CJ ;
DANESHMEND, TK ;
ROBERTS, CJC .
GUT, 1982, 23 (10) :819-823